ESMO Members: Take the CME test
and receive 2 ESMO - MORA point
Learning objectives:
- To understand the pathogenesis of biliary cancers and how underlying liver disease contributes to the development of such cancers and may inform treatment
- To describe mutations and other genetic alterations that inform the current use of both targeted and immune-based therapies in biliary cancers
- To learn about emerging biomarkers under investigation that hold promise for novel drug development in this disease